Treace Medical Concepts Inc
NASDAQ:TMCI

Watchlist Manager
Treace Medical Concepts Inc Logo
Treace Medical Concepts Inc
NASDAQ:TMCI
Watchlist
Price: 2.64 USD 5.6%
Market Cap: 168.2m USD

Treace Medical Concepts Inc
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Treace Medical Concepts Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Treace Medical Concepts Inc
NASDAQ:TMCI
Revenue
$218.9m
CAGR 3-Years
20%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Revenue
$21.8B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
8%
Boston Scientific Corp
NYSE:BSX
Revenue
$19.4B
CAGR 3-Years
15%
CAGR 5-Years
14%
CAGR 10-Years
10%
Stryker Corp
NYSE:SYK
Revenue
$24.4B
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$43.8B
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$9.6B
CAGR 3-Years
16%
CAGR 5-Years
17%
CAGR 10-Years
15%
No Stocks Found

Treace Medical Concepts Inc
Glance View

Market Cap
168.2m USD
Industry
Health Care

Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. The company is headquartered in Ponte Vedra, Florida and currently employs 248 full-time employees. The company went IPO on 2021-04-23. The firm is focused on strategic product development activities that improve surgical efficiencies and patient outcomes. The firm's proprietary Lapiplasty 3-dimensional (3D) Bunion Correction System, which is a combination of instruments, implants and surgical methods designed to correct all three dimensions of the bunion deformity, address the root cause of the bunion deformity. The Lapiplasty System combines novel surgical approach, the Lapiplasty Procedure, with its procedural instrumentation and single-use implant kits. The Lapiplasty Procedure is designed to rotate the entire metatarsal bone into normal anatomical position in all three dimensions, eliminating the bump and restoring normal anatomy. The Lapiplasty Procedure can be performed in either hospital outpatient or ambulatory surgery center settings. The firm's brands include Lapiplasty, Fast Grafter and Plantar Python.

TMCI Intrinsic Value
9.44 USD
Undervaluation 72%
Intrinsic Value
Price

See Also

What is Treace Medical Concepts Inc's Revenue?
Revenue
218.9m USD

Based on the financial report for Sep 30, 2025, Treace Medical Concepts Inc's Revenue amounts to 218.9m USD.

What is Treace Medical Concepts Inc's Revenue growth rate?
Revenue CAGR 5Y
34%

Over the last year, the Revenue growth was 8%. The average annual Revenue growth rates for Treace Medical Concepts Inc have been 20% over the past three years , 34% over the past five years .

Back to Top